Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

Share Price is delayed by 15 minutes
Get Live Data
2.44    -0.005 (-0.20%)
Bid:
2.43
Ask:
2.445
Spread: 0.015 (0.617%)
Market Cap: $8.05b
CBKD Live PriceLast checked at - London Stock Exchange

Intraday Com.int.bk.regs Share Chart

  • This share is an international stock.

CIB's AGM Resolutions Summary

28 Mar 2022 07:00

RNS Number : 1497G
Commercial Intnl Bank (Egypt) SAE
28 March 2022
 

 

 

Ordinary General Assembly

27 March 2022

 

Resolutions Summary

 

 

Item (1-1)

Board of Directors Report for the FY Ended 31/12/2021

 

The General Assembly approved the presented Board of Directors Report for the Financial Year ended 31/12/2021.

 

 

Item (1-2)

 

Governance Report for the FY Ended 31/12/2021

and External Auditors' Reports

 

The General Assembly approved the presented Corporate Governance Report and approved the External Auditors' Independent Limited Assurance Reports for the presented Governance Report.

 

 

Item (1-3)

 

Shareholders' Questions and Requests

 

The Chairman presented the questions and requests received from the shareholders, during the legitimate time for submitting requests, and responded to them. The General Assembly approved the Board of Directors' recommendation for not accepting the request of the shareholder who owns currently 2301 shares (which represent 0.00012% of the Bank's Issued Capital) for raising disputes affecting the public interest of the bank in the name of all the shareholders.

 

Item (2)

 

External Auditors' Reports for the Separate and Consolidated FY

Ended 31/12/2021

The General Assembly was advised with the External Auditors' Report on CIB Separate and Consolidated Financial Statements for the year ended 31/12/2021 and approved the report.

 

1/4

 

 

 

Item (3)

 

Separate and Consolidated Financial Statements

For the FY Ended 31/12/2021

 

The General Assembly approved the separate and consolidated Financial Statements for the year ended 31/12/2021.

 

Item (4)

 

Recommended Appropriation Account

For the FY Ended 31/12/2021

 

The General Assembly approved the proposed Appropriation Account for the year ended 31/12/2021 and delegated the Board of Directors to approve the guidelines for profit distribution to the Bank's employees.

 

The shareholders are entitled to cash dividends payout of approximately 1.35 Egyptian Pound per share for a total number of shares of (1,982,513,360) including the ESOP Year 12 vested shares of (12,271,570), the program that was approved by the Financial Regulatory Authority, and in accordance to the authenticated Amendment Contract of Articles (6) and (7) of the Bank's Bylaws as authenticated by the General Authority for Investment on the 17th of March 2022. The ex-dividend date shall be Monday, the 4th of April 2022 and will be disbursed via Misr for Central Clearing, Depository and Registry "MCCDR" on Thursday, the 7th of April 2022, as notified to Egypt Stock Exchange.

 

Item (5)

 

Increasing the Issued and Paid-in Capital

to Fulfill the ESOP "Year 13"

 

The General Assembly approved the increase of the issued and paid in capital by (16,542,927) common shares at nominal value of EGP 10 per share to effect the vesting terms of the "ESOP" Program for "Year 13", the program that was approved by the Extraordinary GA on the 21st of March 2016 and authenticated by the Financial Regulatory Authority in May 2016.

 

The General Assembly also approved to delegate the Board of Directors to amend Articles (6) and (7) of the Bank's Bylaws to reflect the mentioned increase, subject to the approval of the Central Bank of Egypt. Noting that said increase will be pursued after finalizing the approvals of the relevant authorities on the  capital

 

2/4

 

 

increase of one billion shares for EGP 10 billion to be financed by the general reserve and distributed as free dividend shares to the shareholders as approved by the General Assembly in its meeting on the 30th of March 2021.

 

 

The General Assembly also approved to delegate the Chief Executive Officer & Managing Director to fulfill the capital increases procedural requirements after obtaining the required approvals, with the right to delegate others in doing so, without prejudice to the Listing and Delisting Rules and its Executive Regulations issued by the Financial Regulatory Authority and effected by the Egyptian Stock Exchange, and also approved to delegate Mr. Mohy El Din El Tohamy Ibrahim, Head of the Bank's Legal Department, to sign the amendment agreements of the Bank's Statutes at the respective Notary Office.

 

 

Item (6)

 

Discharging the Board of Directors from all liabilities

for FY Ended 31/12/2021

 

The General Assembly approved discharging the Chair and Members of the Board from all liabilities with regard to the Bank's activities during the financial year 2021.

Item (7)

 

2022 Proposed Remuneration for the Directors of the Board

 

The General Assembly approved remuneration for the Non-Executive Board Members for the FY 2022 to be as follows:

 

· Annual board sitting fees to the chair and each Non-Executive Director for the net amount of EGP 125,000.

 

· Annual committee sitting fees to each Non-Executive Director for the net amount of EGP 110,000 per committee, while the net amount is EGP 122,000 for the committee chair.

 

 

 

 

 

 

 

 

3/4

 

 

 

 

 

 

 

Item (8)

 

Appointment of the Bank's External Auditors

For the Financial Year 2022

And Approving their Fees

 

The General Assembly approved the appointment of Mr. Farid Samir Farid, Partner, (Deloitte - Saleh, Barsoum & Abdel Aziz Auditing Firm) and Mr. Tamer Salah El Din Abdel Tawab Roshdy, Partner, "Pricewaterhouse Coopers - Ezzeldeen, Diab & Co. (Public Accountants)" as the Bank's Auditors for the Financial Year 2022. The General Assembly approved the auditing fees of EGP 2,870,000 (net of VAT) for each auditing firm for auditing the Bank's annual and quarterly standalone and consolidated financial statements and issuing related reports in accordance with the regulations of the Central Bank of Egypt and the Financial Regulatory Authority.

 

Item (9)

 

Authorization to the Board of Directors

to Approve Donations in 2022

 

The General Assembly approved authorizing the Board of Directors to donate over EGP 1000 per recipient during the year 2022 and approved the donated amounted during the financial year 2021.

 

Item (10)

 

Authorization to the Directors

 

The Ordinary General Assembly approved authorizing the Directors to assume full time jobs (technical or administrative) in other shareholding companies in conformity with Article "95" of the Companies Law No. 159 of 1981.

 

 

http://www.rns-pdf.londonstockexchange.com/rns/1497G_1-2022-3-27.pdf

 

 

 

 

 

 

 

 

 

4/4

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGPPURPWUPPGCM
Date   Source Headline
12th May 202610:18 amRNS1st Quarter Results
12th May 202610:16 amRNSCIB Consolidated Financial Statements 1Q26
12th May 202610:15 amRNS1Q26 Earnings Release
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
24th Feb 202612:31 pmRNSItems of Extraordinary GA
24th Feb 20267:00 amRNSPress Release dated 23th February 2026
19th Feb 20261:20 pmRNSItems of Extraordinary GA
19th Feb 20261:17 pmRNSInvitation to the Extraordinary GA 2026
19th Feb 20268:00 amRNSItems of OGA 2026
19th Feb 20268:00 amRNSInvitation to the OGA March 15
10th Feb 20267:00 amRNSCIB Summary of Board Resolution 9 Feb 2026
10th Feb 20267:00 amRNSFY25 Earnings Release
10th Feb 20267:00 amRNSCIB IFRS Consolidated Financial Statements FY25
15th Dec 20257:00 amRNSChange in Board of Directors
3rd Dec 20254:35 pmRNSCIB Bonus Shares Distribution 2025
4th Nov 20257:00 amRNSCIB Condensed Consolidated 3rd Quarter Results
4th Nov 20257:00 amRNSCIB 9M25 Earnings Release
4th Nov 20257:00 amRNS3rd Quarter Results
25th Sep 20253:55 pmRNSSummary of Resolutions - GAM September 2025
1st Sep 20257:02 amRNSInvitation to General Assembly September 2025
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Consolidated Financials
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Separate Financials
22nd Jul 20257:00 amRNS2Q25 Earnings Release
28th May 20256:00 pmRNSChanges to the Board of Directors
13th May 20257:00 amRNSSeparate- Q12025
13th May 20257:00 amRNS1Q25 Press Release
13th May 20257:00 amRNSConsolidated Financial Position at March 31.2025
24th Mar 20257:00 amRNSOrdinary General Assembly Resolutions Summary 2025
28th Feb 20257:00 amRNSGeneral Assembly 2025 - Discussion Items - amended
27th Feb 20257:47 amRNSInvitation to General Assembly 2025
27th Feb 20257:15 amRNSGeneral Assembly 2025 - Discussion Items
19th Feb 20257:00 amRNSCIB Annual Financial Report
19th Feb 20257:00 amRNSCIB FY2024 Earnings Release
6th Nov 20247:58 amRNSCIB gets regulatory approvals to changes to BoD
4th Nov 20247:00 amRNSEarnings Release 3Q.2024
4th Nov 20247:00 amRNSCIB-Separate Financial Statements 3Q.2024
4th Nov 20247:00 amRNSCIB-Consolidated Financial Statements 3Q.2024
1st Oct 20242:00 pmRNSCIB obtaining Long term loan from IFC
16th Sep 20248:00 amRNSChanges in CIB's Board of Directors
22nd Jul 20247:00 amRNSH1.2024 Press Release
22nd Jul 20247:00 amRNSCIB H1-2024 Separate Financial Statements - E
22nd Jul 20247:00 amRNSCIB H1-2024 Consolidated Financial Statements
13th May 20247:00 amRNS1st Quarter Results - Consolidated Statements
13th May 20247:00 amRNS1st Quarter Results - Separate Statements
26th Mar 20247:49 amRNSChanges in CIB's BOD - 25 March 2024
26th Mar 20247:00 amRNSEGM Resolutions - March 25th, 2024
26th Mar 20247:00 amRNSOGM Resolutions - March 25th, 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.